Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Vemurafenib × Clear all

Phase

Status

Completed 51 Terminated 21 Recruiting 14 Active not recruiting 13 Unknown 11 Withdrawn 7 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cisplatin 107 Carboplatin 105 Drug Therapy 103 Oxaliplatin 90 Capecitabine 84 Bevacizumab 83 Paclitaxel 78 Cyclophosphamide 76 pembrolizumab 74 Radiotherapy 74 Gemcitabine 74 tislelizumab 70 Specimen Handling 57 toripalimab 55 Fluorouracil 55 Docetaxel 53 Surgical Procedures, Operative 49 Injections 48 sintilimab 47 Magnetic Resonance Spectroscopy 47 130-nm albumin-bound paclitaxel 44 Leucovorin 38 Pemetrexed 37 Biopsy 37 fludarabine 36 anlotinib 36 Standard of Care 35 Immune Checkpoint Inhibitors 35 lenvatinib 34 Radiosurgery 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06692491 2024-11-18

SPRING

Peking University Shenzhen Hospital

Phase 2 Not yet recruiting

Rare Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡